Skip to main content

You thought your periods were over. So why are you bleeding again?

Postmenopausal bleeding occurs in approximately 4-11% of postmenopausal women. Of those, ~90% have benign causes (atrophy 60%, polyps 25-30%), and ~9% have endometrial cancer. Cancer risk increases with age: <1% under 50, up to 24% over 80.

Thanks for this. I recently have experienced bleeding and in menopause. My Gynecologist ordered an ultrasound and I've been putting it off since I just got a new job. Will make an appointment today.

via Reddit·2 engagement
24 discussions·2 platforms·Stable
By Wellls Editorial Team·48+ peer-reviewed sources·

For informational purposes only. Not a substitute for professional medical advice.

Key takeaways

  • Postmenopausal bleeding affects 4-11% of women after menopause.
  • About 9% of cases are endometrial cancer; 90% are benign (atrophy, polyps).
  • All cases require medical evaluation.
  • Estrogen-dependent tissue atrophy of endometrium and vaginal walls
Take our free postmenopausal bleeding self-assessment5 questions · 2-3 min · private & free

The Science Behind Postmenopausal Bleeding

Approximately 9% of women who present with postmenopausal bleeding have endometrial cancer. That means 91% of the time, the cause is benign: atrophy (60%), polyps (25-30%), or HRT-related changes. But the 9% is not a number you ignore, because 90% of women diagnosed with endometrial cancer first presented with bleeding. It is one of the most reliable early warning signs in oncology.

I need you to hold both of those numbers simultaneously because the tension between them is the entire story of postmenopausal bleeding. Nine percent cancer risk means your odds are overwhelming that this is not cancer. Ninety percent cancer detection through bleeding means this is one of the few cancers that announces itself early enough to catch. The Clarke et al. meta-analysis pooled data from 129 studies involving over 34,000 women and confirmed this pattern across populations, age groups, and geographic regions. Postmenopausal bleeding has a positive predictive value for endometrial cancer that most screening tools in oncology would envy.

Here is what the statistics do not capture: the 3am terror of seeing blood on the toilet paper when you believed menopause had ended that chapter of your life. The Google search at 3:15am that shows you the word cancer before it shows you the word atrophy. The days of waiting for an appointment during which your mind builds a narrative that the evidence does not support. I have talked to women who spent two weeks convinced they were dying before an ultrasound revealed a benign polyp that explained everything. The emotional cost of postmenopausal bleeding is disproportionate to the statistical risk, and I think acknowledging that matters as much as presenting the data. You are allowed to be frightened and statistically likely to be fine. Both things can be true at the same time.

1

Why estrogen loss makes postmenopausal tissues bleed

After menopause, declining estrogen causes the endometrial lining and vaginal epithelium to thin dramatically. These tissues lose collagen, elasticity, and blood supply. The endometrium becomes fragile enough to shed spontaneously. The vaginal walls become thin enough to tear from minimal friction, from a pelvic exam, or sometimes from nothing at all. I have read accounts of women who noticed postmenopausal bleeding simply from wiping after the toilet. No contact. No trauma. Just tissue that had become too thin to hold together.

The NAMS 2020 position statement on genitourinary syndrome of menopause estimates that up to 84% of postmenopausal women experience these tissue changes. That is not a fringe number. That is the overwhelming majority. And unlike hot flashes, which tend to peak and then recede over years, GSM worsens progressively without treatment. Year after year, the tissues thin further. The Lethaby et al. systematic review confirmed that low-dose vaginal estrogen reverses much of this damage and does not significantly raise systemic estrogen levels. The AUA/SUFU/AUGS 2024 guideline lists it as first-line treatment. And yet, in my experience covering this topic, most women with GSM never receive treatment because they believe thinning, dryness, and bleeding are just the inevitable cost of aging. They are not.

I want to be specific about what estrogen withdrawal does at the cellular level because the clinical language of 'atrophy' hides the mechanism that matters. Estrogen maintains the vaginal epithelium at 20-40 cell layers thick in premenopausal women. Each layer provides structural integrity and moisture. After menopause, without estrogen, that epithelium thins to as few as 3-5 cell layers. The difference is visible under a microscope: thick, pink, well-vascularised tissue versus thin, pale, fragile tissue with reduced blood supply. Dr. Risa Kagan at Sutter Health has published extensively on this progression, documenting that the pH of the vaginal environment rises from a protective 3.5-4.5 to a vulnerable 5.0-7.0, creating conditions that favour both tissue breakdown and infection.

The clinical term for postmenopausal bleeding caused by atrophy is 'atrophic vaginitis,' and it accounts for approximately 60% of all cases. But calling it a type of 'vaginitis' is misleading because it implies infection or inflammation from an external agent. The tissue is not infected. It is structurally compromised by hormone withdrawal. It bleeds because it is too thin to withstand the forces of daily life: wiping, sitting, walking, existing. And the treatment that reverses it, low-dose vaginal estrogen, is one of the most evidence-backed and underused interventions in women's healthcare.

2

The 4mm threshold that decides your next step after postmenopausal bleeding

Transvaginal ultrasound is the first-line investigation for postmenopausal bleeding. Every guideline agrees on this. The critical measurement is endometrial thickness. At 4 millimeters or below, the risk of endometrial cancer is less than 1%, and the ACR and ACOG guidelines do not require endometrial sampling at that point. That number should stick in your mind: 4mm.

Above 4mm, or with persistent postmenopausal bleeding regardless of thickness, biopsy is the next step. An endometrial biopsy involves inserting a thin catheter through the cervix to collect a tissue sample. It hurts. I am not going to pretend otherwise. Women describe a sharp cramp lasting 30 to 60 seconds, sometimes longer if cervical access is difficult. One woman in our community said her cervix was twisted and she demanded strong pain medication before the procedure. She was right to do so.

Dreisler et al. found that contrast-enhanced sonohysterography significantly improves diagnostic accuracy for detecting intrauterine pathology compared to standard ultrasound alone. If your initial scan is inconclusive, ask your provider about contrast imaging. I think it is underused.

The key message here is that the ultrasound is not designed to scare you. It is designed to triage: do we need tissue, or can we reassure you without it? And if tissue is needed, Visser et al.'s longitudinal data reminds us that a single reassuring biopsy does not guarantee safety forever. Women with endometrial thickness above 4mm and initial hyperplasia without atypia had elevated cancer risk over the following four years. Follow-up is not optional. It is part of the plan.

I want to add something about the biopsy experience that most medical resources skip because they are written by people who have never had one. The endometrial biopsy is performed in an office setting, usually without anaesthesia. The Pipelle catheter is thin, roughly 3mm in diameter, and the procedure takes 30 to 90 seconds. But those seconds can range from mildly uncomfortable to genuinely painful depending on cervical anatomy, menopausal status, and individual pain sensitivity. Postmenopausal women often have cervical stenosis, narrowing of the cervical canal from estrogen withdrawal, which makes catheter insertion more difficult.

If you are scheduled for a biopsy, ask whether you can take 800mg ibuprofen an hour beforehand. Ask whether your provider offers a local cervical block. Ask whether misoprostol to soften the cervix is an option. These are reasonable requests that can meaningfully reduce discomfort, and the fact that most clinics do not offer them by default reflects a normalisation of women's procedural pain that I find unacceptable. You have the right to pain management for a painful procedure. Ask for it.

Key mechanisms

Estrogen-dependent tissue atrophy of endometrium and vaginal wallsEndometrial polyp overgrowth in low-estrogen environmentEndometrial hyperplasia from unopposed estrogen exposureHRT-related unscheduled bleeding from endometrial stimulation

Deep scientific content for Postmenopausal bleeding is coming in Wave 3.

Our team is reviewing research papers and clinical guidelines.

Your Postmenopausal bleeding Program

We're building a personalized lifestyle medicine course for postmenopausal bleeding, based on the latest research and real experiences.

Course coming soon

Talk to Dr. Wellls — free consultation

4 free messages — no account required

Dr. Wellls AI

Online now

Quick start — tap or speak:

Powered by Lifestyle Medicine evidence. Not a substitute for medical advice.

You're Not Alone

0

women are talking about postmenopausal bleeding right now

Thousands of women have been through the same thing. Here's what they say.

redditSharing

I'm in the exact same boat: bleeding after two years in menopause (and on HRT) and will be having my biopsy on Monday. The fun part is my cervix is twisted, so access to my uterus is tricky. I demanded the heavy duty drugs and got em. Wish me luck.

redditSharing

My doctor says 'any bleeding after menopause is cancer until proven otherwise.' That got my attention!

redditSharing

Dottie's daughters: Laura in her late 30's had irregular bleeding, went to her doctor, got a biopsy. Cancer and hysterectomy. Caught early, no chemo needed. Daisy had postmenopausal bleeding and ignored it for a year. She ended up needing radiation. Don't be...

+ 2 more stories from real women

Understanding Your Postmenopausal Bleeding

A brief assessment to understand your bleeding pattern and what steps you should take next. This is not a condition to wait on.

Your severity level — mild, moderate, or significant
What’s driving YOUR postmenopausal bleeding specifically
A personalized next step from Dr. Wellls

1,869 women got their profile this month

Free · 5 min · 100% private

This is not a clinical assessment. For medical concerns, consult a healthcare provider.

Take a moment for yourself

These evidence-based techniques can help manage postmenopausal bleeding symptoms right now.

Ready
Movement for Postmenopausal bleeding

Curated Exercise Sets

4 personalized routines with 16 exercises from professional trainers

Quick Relief

Postmenopausal Bleeding — Quick Relief

5 minBeginner2
Mish Naidoo

Mish Naidoo

Professional Trainer

Morning

Postmenopausal Bleeding — Morning Activation

15 minBeginner4
Petra Kapiciakova

Petra Kapiciakova

Professional Trainer

The many faces of postmenopausal bleeding

4 distinct patterns we've identified from real women's experiences

Any vaginal bleeding that occurs 12 or more months after your last menstrual period is classified as postmenopausal bleeding. It is never considered normal. That does not mean it is always dangerous. But it does mean it always requires evaluation. No exceptions.

From our data

Here is the number that should both alarm and reassure you: approximately 90% of postmenopausal bleeding is caused by benign conditions. Atrophy alone accounts for up to 60% of cases. Polyps cover another 30%. But the remaining 9 to 10% is endometrial cancer. One in ten. That is not a number you ignore.

Meta-analysis of 129 studies: 9% cancer risk in women with P...Atrophy causes ~60% of PMB, polyps ~30%, cancer ~10%...Transvaginal ultrasound is ideal first-line evaluation; cont...

Your personalized protocol

A lifestyle medicine approach to postmenopausal bleeding, built on 6 evidence-based pillars

Weeks 1-2stress

Complete your evaluation

Ensure you have your ultrasound results and any biopsy scheduled. If results are reassuring, discuss ongoing monitoring frequency with your provider.

Weeks 3-4nutrition

Address GSM fully

If atrophy is diagnosed, begin vaginal estrogen or moisturizer treatment. Consistency matters more than product choice. Use vaginal moisturizer 2-3 times per week and estrogen as prescribed.

Weeks 5-8movement

Maintain pelvic floor health

Pelvic floor exercises support vaginal tissue integrity and urinary health. GSM affects the entire g...

Unlock in your plan
Weeks 9-12stress

Schedule annual follow-up

Even if initial evaluation is benign, annual gynecological evaluation is important. Visser et al.'s ...

Unlock in your plan

1,800+ women explored their postmenopausal health profile this month

Start your protocol

How Postmenopausal bleeding affects your body

Tap body zones to discover connected symptoms and related conditions.

Join 101+ women discussing postmenopausal bleeding

0 women in this community

Real experiences shared across Reddit, TikTok, and health forums

II
Sharing experiencereddit8w ago

I’m in the exact same boat: bleeding after two years in menopause (and on HRT) and will be having my biopsy on Monday. The fun part is my cervix is twisted, so access to my uterus is tricky. I...

YS
Sharing experiencetiktok74w ago

You should Never have this symptom after menopause! #menopause #perimenopause #postmenopause #postme

You should Never have this symptom after menopause! #menopause #perimenopause #postmenopause #postmenopausal #drjencaudle #fyp #fypシ #fypシ゚viral

“W
Sharing experiencereddit7w ago

“ Why Postmenopausal Bleeding Requires Immediate Medical Evaluation: Rule Out Cancer: The primary reason for evaluation is to rule out endometrial (uterine) or cervical cancer, which is the cause in...

Reading others' stories is the first step. Join to share yours.

Community

A safe space for women navigating postmenopausal bleeding

No stories in this category yet. Be the first to share.

Frequently asked questions

Common questions about Postmenopausal bleeding

No. Approximately 90% of postmenopausal bleeding is caused by benign conditions. Vaginal and endometrial atrophy, the thinning and fragility of tissues due to estrogen loss, accounts for about 60% of cases. Endometrial polyps cause another 25 to 30%. However, approximately 9% of women who present with postmenopausal bleeding do have endometrial cancer, according to Clarke et al.'s meta-analysis of 129 studies. That 9% is why every instance of bleeding after menopause requires medical evaluation. The investigation is brief and the relief of a benign result is worth the discomfort.
The most common cause is vaginal or endometrial atrophy from estrogen deficiency, responsible for about 60% of cases. Endometrial polyps cause 25 to 30%. Endometrial hyperplasia, a precancerous thickening of the uterine lining, accounts for about 5 to 10%. Endometrial cancer accounts for roughly 9 to 10%. Other causes include cervical polyps, infection, blood thinners, and hormone replacement therapy side effects. The Cleveland Clinic and StatPearls reviews agree on these proportions. Regardless of suspected cause, postmenopausal bleeding always warrants evaluation because symptoms alone cannot distinguish benign from malignant causes.
Yes, and it should be evaluated promptly. Bleeding after 10 years of menopause is actually more concerning than bleeding shortly after, because the longer you are postmenopausal, the higher the proportion of bleeding caused by cancer versus benign causes. Clarke et al.'s data showed that cancer risk in women with postmenopausal bleeding increases with age: less than 1% in women under 50, rising to 24% in women over 80. Atrophy can also worsen over time, so benign causes remain possible. But the urgency of investigation increases, not decreases, with time since menopause.
How we research and fact-check

Every article on Wellls is researched using peer-reviewed medical literature, clinical guidelines, and real patient experiences from 24 online discussions.

Sources: We reference PubMed-indexed studies, ACOG/NAMS clinical guidelines, and validated screening tools. Each page cites 48 evidence-based sources.

Process: Content is written by our editorial team, cross-referenced with RAG (Retrieval-Augmented Generation) from our medical knowledge base of 15,000+ sources, and reviewed for clinical accuracy.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment.

References

48 sources reviewed for this postmenopausal bleeding guide

  1. 1.
  2. 2.
    Glynne S et al. Endometrial thickness and pathology in PMB women on HRT
  3. 3.
    Dreisler E et al. Perimenopausal abnormal uterine bleeding
  4. 4.
    Marachapu J & Vij S Histopathological Spectrum of Endometrial Lesions in Women with AUB
  5. 5.
    NAMS Role of progestogen in HRT for postmenopausal women: NAMS position
  6. 6.
    Meta-analysis Association Between HRT and Development of Endometrial Cancer
  7. 7.
    Clinical review Diagnostic Efficacy of Hysteroscopy
  8. 8.
    Expert book The Definitive Guide to the Perimenopause and Menopause
  9. 9.
    Clinical review Abnormal uterine bleeding in perimenopause
  10. 10.
    Qualitative study Pilot study of women's perspectives when AUB occurs in perimenopause
History of updates

Current version (March 11, 2026) — Content reviewed and updated based on latest research

First published (March 7, 2026)

Your personalized plan is ready

If you're scared about postmenopausal bleeding and want to understand exactly what it means for you specifically, our severity assessment walks you through your personal risk factors and gives you a clear action plan for your doctor's appointment. Because knowing what to expect removes half the fear.

1,800+ women explored their postmenopausal health profile this month

Free assessment · Takes 2 minutes · No account required

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personal medical decisions. Content is based on peer-reviewed research and updated regularly. Learn about our editorial standards.